Response rates and toxicity profile of neoadjuvant immunotherapy in early-stage triple negative breast cancer (TNBC) - Multi institute experience

被引:0
|
作者
Khalid, F. [1 ]
Attia, M. [2 ]
Mehmood, T. [3 ]
Shah, N. [2 ]
Baki, M. [1 ]
机构
[1] East & North Hertfordshire NHS Trust, Lister Hosp, Stevenage, England
[2] East & North Hertfordshire, Mt Vernon Canc Ctr, Northwood, England
[3] Univ Hosp Northamptonshire NHS Grp, Kettering, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Early prediction of response to Neoadjuvant Immunotherapy in Triple Negative Breast Cancer (TNBC) with DCEMRI
    Rauch, Gaiane
    Guirguis, Mary
    Patel, Miral
    Candelaria, Rosalind
    Mohamed, Rania
    Moseley, Tanya
    Le-Petross, H. T. Carisa
    Leung, Jessica
    Whitman, Gary
    Lane, Deanna
    Scoggins, Marion
    Perez, Frances
    Sun, Jia
    Pashapoor, Sanaz
    Xu, Zhan
    White, Jason
    Wei, Peng
    Reed, Brandy
    Son, Jong Bum
    Hwang, Ken-Pin
    Panthi, Bikash
    Korkut, Anil
    Huo, Lei
    Hunt, Kelly
    Clayborn, Alyson
    Litton, Jennifer
    Valero, Vicente
    Tripathy, Debu
    Yam, Clinton
    Yang, Wei
    Ma, Jingfei
    Adrada, Beatriz
    CANCER RESEARCH, 2024, 84 (09)
  • [2] Prospect of neoadjuvant/adjuvant immunotherapy in early-stage triple-negative breast cancer
    Hao, Xiaopeng
    Gao, Xianqi
    Yin, Shanshan
    Jiang, Zefei
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
  • [3] The impact of gut microbial composition on response to neoadjuvant chemotherapy (NACT) in early-stage triple negative breast cancer (TNBC).
    Abuhadra, Nour
    Chang, Chia-Chi
    Yam, Clinton
    White, Jason B.
    Ravenberg, Elizabeth
    Lim, Bora
    Ueno, Naoto T.
    Litton, Jennifer Keating
    Arun, Banu
    Damodaran, Senthil
    Murthy, Rashmi Krishna
    Ibrahim, Nuhad K.
    Hortobagyi, Gabriel N.
    Valero, Vicente
    Tripathy, Debu
    Thompson, Alastair Mark
    Mittendorf, Elizabeth A.
    Huo, Lei
    Moulder, Stacy L.
    Jenq, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Prospective evaluation of the gut microbiome and response to neoadjuvant therapy (NAT) in early-stage triple negative breast cancer (TNBC)
    Abuhadra, Nour
    Chang, Chia-Chi
    Yam, Clinton
    Sun, Ryan
    Huo, Lei
    White, Jason
    Ravenberg, Elizabeth E.
    Litton, Jennifer
    Lim, Bora
    Ueno, Naoto T.
    Arun, Banu
    Tripathy, Debu
    Damodaran, Senthil
    Murthy, Rashmi
    Valero, Vicente
    Hortobagyi, Gabriel
    Ibrahim, Nuhad
    Thompson, Alastair
    Mittendorf, Elizabeth
    Moulder, Stacy
    Jenq, Robert
    CANCER RESEARCH, 2021, 81 (04)
  • [5] Immunotherapy for Early-Stage Triple-Negative Breast Cancer
    Burstein, Harold J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (21): : 2048 - 2049
  • [6] Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer (TNBC)
    Wein, Lironne
    Loi, Sherene
    BREAST, 2017, 34 : S27 - S30
  • [7] Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer
    Perry, Lauren M.
    Sevilimedu, Varadan
    Polidorio, Natalia
    Abuhadra, Nour
    Morrow, Monica
    Plitas, George
    Downs-Canner, Stephanie
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S102 - S102
  • [8] Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer
    Perry, Lauren M.
    Sevilimedu, Varadan
    Polidorio, Natalia
    Abuhadra, Nour
    Morrow, Monica
    Plitas, George
    Downs-Canner, Stephanie
    ANNALS OF SURGICAL ONCOLOGY, 2025, : 3991 - 4001
  • [9] Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?
    Song, Fei
    Tarantino, Paolo
    Garrido-Castro, Ana
    Lynce, Filipa
    Tolaney, Sara M.
    Schlam, Ilana
    CURRENT ONCOLOGY REPORTS, 2024, 26 (01) : 21 - 33
  • [10] Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?
    Fei Song
    Paolo Tarantino
    Ana Garrido-Castro
    Filipa Lynce
    Sara M. Tolaney
    Ilana Schlam
    Current Oncology Reports, 2024, 26 : 21 - 33